 | Up a level |
Ambrodji, Alisa; Sadlon, Angélique; Amstutz, Ursula; Hoch, Dennis; Berger, Martin D.; Bastian, Sara; Offer, Steven M; Largiadèr, Carlo R. (2024). Approach for Phased Sequence-Based Genotyping of the Critical Pharmacogene Dihydropyrimidine Dehydrogenase (DPYD). International journal of molecular sciences, 25(14) MDPI 10.3390/ijms25147599
Zhang, Ting; Ambrodji, Alisa; Huang, Huixing; Bouchonville, Kelly J; Etheridge, Amy S; Schmidt, Remington E; Bembenek, Brianna M; Temesgen, Zoey B; Wang, Zhiquan; Innocenti, Federico; Stroka, Deborah; Diasio, Robert B; Largiadèr, Carlo R; Offer, Steven M (2024). Germline cis variant determines epigenetic regulation of the anti-cancer drug metabolism gene dihydropyrimidine dehydrogenase (DPYD). eLife, 13 eLife Sciences Publications 10.7554/eLife.94075
Amstutz, Ursula; Henricks, Linda M; Offer, Steven M; Barbarino, Julia; Schellens, Jan H M; Swen, Jesse J; Klein, Teri E; McLeod, Howard L; Caudle, Kelly E; Diasio, Robert B; Schwab, Matthias (2018). Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update. Clinical pharmacology and therapeutics, 103(2), pp. 210-216. Wiley 10.1002/cpt.911
Amstutz, Ursula; Offer, Steven M; Sistonen, Johanna; Joerger, Markus; Diasio, Robert B; Largiadèr, Carlo Rodolfo (2015). Polymorphisms in MIR27A Associated with Early-Onset Toxicity in Fluoropyrimidine-Based Chemotherapy. Clinical cancer research, 21(9), pp. 2038-2044. American Association for Cancer Research 10.1158/1078-0432.CCR-14-2817
